Folotyn prices near Beaumont, TX
Lowest: Unknown Highest: Unknown
What is Folotyn?
USES: Pralatrexate is used to treat a certain type of cancer known as Peripheral T-Cell Lymphoma (PTCL). Pralatrexate works by killing cancer cells.
How to take Folotyn
HOW TO USE: Read the Patient Information Leaflet available from your pharmacist before you start using pralatrexate and each time you get a refill. If you have any questions, ask your doctor or pharmacist. This medication is given by a health care professional in a clinic or hospital. It is injected into a vein, usually over 3 to 5 minutes, once a week for 6 weeks. Tell your doctor or nurse right away if you notice redness, pain, or swelling during your injection. Dosage is based on your body size, medical condition, and response to treatment, including side effects. You should avoid contact with this medication on the skin. If this occurs, immediately wash with soap and water. If this medication gets in the eyes, rinse with water. To get the most benefit from this medication, do not miss any doses. To help you remember, mark the days on the calendar when you need to receive the medication. Your doctor may also direct you to take folic acid and give you vitamin B12 shots to help prevent mouth sores from pralatrexate treatment.
What if I miss a dose of Folotyn?
MISSED DOSE: For the best possible benefit, it is important to receive each scheduled dose of this medication as directed. If you miss a dose, contact your doctor or pharmacist right away to establish a new dosing schedule.
STORAGE: Not applicable. This medication is given in a hospital or clinic and will not be stored at home.
Side Effects of Folotyn
SIDE EFFECTS: Redness or sores of the mouth/lips/throat, or nausea, may occur. If any of these effects persist or worsen, tell your doctor or pharmacist promptly. Remember that your doctor has prescribed this medication because he or she has judged that the benefit to you is greater than the risk of side effects. Many people using this medication do have serious side effects. Serious skin reactions can occur. Tell your doctor right away if you develop rash, peeling, sores or blisters on the skin. Tell your doctor right away if any of these unlikely but serious side effects occur: signs of infection (such as fever, cough, sore throat, chills), easy bleeding/bruising, dehydration, feeling weak, looking pale, shortness of breath. A very serious allergic reaction to this drug is rare. However, get medical help right away if you notice any symptoms of a serious allergic reaction, including: rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, trouble breathing. This is not a complete list of possible side effects. If you notice other effects not listed above, contact your doctor or pharmacist. In the US - Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088 or at www.fda.gov/medwatch. In Canada - Call your doctor for medical advice about side effects. You may report side effects to Health Canada at 1-866-234-2345.
Interactions with Folotyn
DRUG INTERACTIONS: Drug interactions may change how your medications work or increase your risk for serious side effects. This document does not contain all possible drug interactions. Keep a list of all the products you use (including prescription/nonprescription drugs and herbal products) and share it with your doctor and pharmacist. Do not start, stop, or change the dosage of any medicines without your doctor's approval. Some of the products that may interact with this drug include: NSAIDs (such as ibuprofen, naproxen), probenecid, sulfa antibiotics (such as trimethoprim/sulfamethoxazole). Check all prescription and nonprescription medicine labels carefully since many contain pain relievers/fever reducers (NSAIDs) which can increase the risk of side effects when used with pralatrexate. Ask your pharmacist about the safe use of those products.
PRECAUTIONS: Before using pralatrexate, tell your doctor or pharmacist if you are allergic to it; or if you have any other allergies. This product may contain inactive ingredients, which can cause allergic reactions or other problems. Talk to your pharmacist for more details. Before using this medication, tell your doctor or pharmacist your medical history, especially of: kidney disease. Do not have immunizations/vaccinations without the consent of your doctor. Avoid contact with people who have recently received live vaccines (such as flu vaccine inhaled through the nose). To lower the chance of getting cut, bruised, or injured, use caution with sharp objects like razors and nail cutters, and avoid activities such as contact sports. Before having surgery, tell your doctor or dentist about all the products you use (including prescription drugs, nonprescription drugs, and herbal products). This medication is not recommended for use during pregnancy. It may harm an unborn baby. If you become pregnant or think you may be pregnant, tell your doctor right away. It is unknown whether this drug passes into breast milk. Because of the potential harm to a nursing infant, breast-feeding while using this drug is not recommended. Consult your doctor before breast-feeding.
Conditions Commonly Treated by Folotyn
Prescription prices may vary from pharmacy to pharmacy and are subject to change. The pricing estimates given are based on the most recent information available and may change based on when you actually fill your prescription at the pharmacy. The day supply is based upon the average dispensing patterns or the specific drug and strength. The Program, as well as the prices and the list of covered drugs, can be modified at any time without notice.
Blog Posts Related to Folotyn
Patients in the United States who suffer from mantle cell lymphoma have a new treatment option available following the US Food and Drug Administration's (FDA's) decision to grant accelerated approval to Calquence (acalabrutinib). The AstraZeneca Pharmaceuticals drug was granted Priority Review,...
The US Food and Drug Administration (FDA) has given the nod to Yescarta (axicabtagene ciloleucel), the first cell-based gene therapy granted approval for the treatment of certain types of non-Hodgkin lymphoma (NHL) and only the second gene therapy to gain FDA approval.
The drug is indicated for...
A new treatment will soon be available for adults with relapsed follicular lymphoma, a slow-growing form of non-Hodgkin lymphoma, following the US Food and Drug Administration's (FDA) approval of Aliqopa (copanlisib). The drug was granted Accelerated Approval as it fills an unmet medical need....
Similar Drugs To Folotyn & Other Folic Acid Analogs